ZIOP

Ziopharm rises on preclinical cancer therapy study

moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma

[at noodls] – Restructuring to Place Exclusive Strategic Focus on Synthetic Biology Programs Company to Host Conference Call Today, March 26, 2013 at 8:30 AM ET NEW YORK, March 26, 2013 (GLOBE NEWSWIRE) — ZIOPHARM … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here […]

ZIOPHARM Oncology Initiates Phase 2 Study of Ad-RTS IL-12 and Palifosfamide Combination for Treatment of Advanced Breast Cancer

[at noodls] – NEW YORK, March 11, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

ZIOPHARM Oncology to Present at the Barclays Global Healthcare Conference

[at noodls] – NEW YORK, March 7, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the Barclays Global Healthcare … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

Phase 3 Trial of ZIOPHARM’S Palifosfamide in First-Line Metastatic Soft Tissue Sarcoma Reaches Target Number of Progression-Free Survival Events

[at noodls] – NEW YORK, Feb. 12, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

Solasia Announces New Executive Leadership, Clinical Activities, and China Operations

[Business Wire] – TOKYO–(BUSINESSWIRE)– Solasia Pharma K.K. announced today a change in its executive leadership team. Yoshihiro Arai, currently General Manager and Head of Development of Solasia Pharma K.K., has been … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to view […]

ZIOPHARM Oncology to Present at the 15th Annual BIO CEO & Investor Conference

[at noodls] – NEW YORK, Feb. 6, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 15th Annual BIO CEO & Investor … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here […]

ZIOPHARM Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – NEW YORK, Jan. 3, 2013 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 31st Annual J.P. Morgan Healthcare … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboardSee who ZIOPHARM is hiring next, click here to […]

ZIOPHARM Oncology to Participate in the 2012 Deutsche Bank BioFEST Conference

[at noodls] – NEW YORK, Nov. 28, 2012 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced today that Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, will present at the 2012 Deutsche Bank BioFEST … moreView todays social media effects on ZIOPView the latest stocks trending across Twitter. Click to view dashboard […]